Home/Pipeline/DNAscope (short reads)

DNAscope (short reads)

Germline Variant Discovery

CommercialActive

Key Facts

Indication
Germline Variant Discovery
Phase
Commercial
Status
Active
Company

About Sentieon

Sentieon is a leading provider of high-performance, software-only bioinformatics solutions for genomic secondary analysis, serving research, clinical, and conservation clients. Its core technology offers drop-in, accelerated replacements for industry-standard tools like BWA-MEM and GATK, delivering significant improvements in speed (e.g., <30 minutes for a 30x whole genome) and cost-efficiency on generic CPU/ARM hardware. The company has established strong validation through customer publications and precisionFDA challenge wins, processing millions of samples for over 1,800 trusted clients. Sentieon operates as a private, revenue-generating platform company capitalizing on the growing computational demands of large-scale genomics.

View full company profile